Skip to main content Help with accessibility Skip to main navigation

All Guidance

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Pending
Date Posted: 14 - January - 2021
BNF chapter: Cardiovascular system
Adopted
Adopted
Pending
Adopted
Adopted
Pending
Adopted
Adopted
Date Posted: 24 - October - 2022
BNF chapter: Cardiovascular system
Adopted
Adopted
Pending
Adopted
Adopted
Pending
Adopted
Pending
Date Posted: 13 - May - 2022
BNF chapter: Cardiovascular system
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Pending
Date Posted: 20 - January - 2022
BNF chapter: Cardiovascular system

Please refer to the LSCMMG inclisiran medicines entry for further information on use within Lancashire and South Cumbria - RAG rated 'Green (Restricted)'.

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 14 - June - 2022
BNF chapter: Cardiovascular system
For the symptomatic treatment of chronic stable angina or chronic heart failure Information for prescribers - to be read in conjunction with the SPC
Adopted
Adopted
Pending
Adopted
Adopted
Pending
Adopted
Pending
Date Posted: 20 - July - 2022
BNF chapter: Cardiovascular system

LSCMMG endorses the 'Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD' produced by the Accelerated Access Collaborative Clinical Subgroup

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - March - 2018

This guidance has been produced to facilitate the safe prescribing of LMWHs in primary care. It provides an overview of points to be considered when initiating LMWHs and when transferring prescribing responsibilities to or from another organisation.